I received the compound earlier this week. The compound has been sent for NMR testing and all of the US orders have been shipped and should be arriving tomorrow. The international orders will be shipping tomorrow morning and hopefully you will be receiving it next week. I will provide tracking information when I can.
Good luck everyone.
YES!! :D Awesooome!
Now this, this be exciting! First ever truly, well-documented selective Kappa-antagonist trial in the wild! I am very very pleased by this news.
Now, on to some of the specifics of trialling a drug such as this - we probably need to give it about the same time as a regular antidepressant to actually gain full efficacy - yes, in theory the effects are immediate, within minutes, like other opiates, BUT... we can't be entirely certain about that - so if you trial it, give it a full couple of weeks before you write it off - the effects may be subtle at first.
And then we have the dosing - what dosing did the studies use, again? 10 mg? We have to remember, that this is not a hard number - it's a lot like any other drug, there are individual dosing-differences - some of you may require only 5 mg, while others may require 15 mg.
And then finally, we have the issue of potential UP-regulation of the kappa-receptors, as a result of antagonism - DOWN-regulation of the Kappa's have been reported when the use of low doses of kappa-agonists have been implemented, resulting in antidepressant action. This is problematic... because it COULD imply that the kappa-receptor system is especially prone towards over-regulation, in order to correct imbalances. However, many receptor-systems only seem to regulate heavily up or down in ONE direction, not the other.
So, it's not a given that this will happen, but still, we need to be prepared for it: set aside a few smaller than average dosages, to be used for the end of your trials - these will then be your tapering dosages, so as to avoid any grave upregulation of the kappa-receptor.
NOW THEN... how often should one dose? Once-daily, orally, seems to be an effective method in the trials, and the half-life is pretty good, up to 40 hours, which makes it unlikely to induce any severe discontinuation-symptoms, judging from other compounds with such a half-life. (other AD's)
Looking at the half-life duration of action of other opiate ligands, I find that the effects of agonists appear to last LONGER than their half-life...! 0_o The half-life of agonists all appear to be utterly pitiful as well - no wonder people get addicted! Those drugs have absolutely disgusting pharmacokinetics.
Looking at the more comparable antagonists, Naloxone and Naltrexone, the half-life and DOA seems to either follow each other, or once again, the DOA IS MANY TIMES LONGER THAN HALF-LIFE! 0_o
The implications here are CRAZY! Perhaps we should not worry too much about upregulation after all... these effects are quite encouraging.
References:
-----------------------
Evaluation of CERC-501, a selective kappa opioid antagonist in preclinical models of alcoholismhttp://www.drugandal...0442-2/abstract
"...daily administration of 10mg/kg CERC-501 reduced ethanol consumption on four consecutive test days, indicating that it did not produce significant tolerance"
Major Depressive Disorder and Kappa Opioid Receptor Antagonists
https://www.ncbi.nlm...les/PMC4871611/
"In mouse forced swim assays, 10 mg/kg oral dose of CERC-501 was found to reduce immobility responses... A synergic effect was also observed for CERC-501 (3 mg/kg, po) and citalopram (3 mg/kg, ip) in combination...
In clinical trials, CERC-501 displayed rapid oral absorption and a terminal half-life of approximately 30–40 hours in healthy subjects [107]. Plasma exposure of CERC-501 increased proportionally with increasing doses and reached steady state after 6–8 days for once-daily dosing [107]."
(All I keep finding is the data from bloody mice-testing... where's the human dosing at?? Of course, we could just recalculate - humans generally use LOWER dosages of drugs than mice)
Incorporating Alcohol Pharmacotherapies Into Medical Practice.
https://www.ncbi.nlm...books/NBK64042/
"Naltrexone's duration of action (which is greater than 24 hours) allows a variety of flexible dosing schedules."